Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support enalapril for renal protection in diabetic nephropathy; hypothesis-generating and needs larger confirmatory trials.
TherapeuticsJuly 1, 1992Enalapril for diabetic nephropathyJacqueline A. Pugh, MDJacqueline A. Pugh, MDAudie L. Murphy Memorial Veterans Hospital San Antonio, Texas (J.A.P.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1992-117-1-012 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationBjörck S, Mulec H, Johnsen SA, Nordén G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992 Feb 8;304:339-43.Reference1 Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991; 303:81-7. Google Scholar Author, Article, and Disclosure InformationAffiliations: Audie L. Murphy Memorial Veterans Hospital San Antonio, Texas (J.A.P.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails July 1, 1992Volume 117, Issue 1Page: 12KeywordsACE inhibitorsAcidsAlbuminsAnimal modelsBlood pressureEnzyme inhibitorsEnzymesExcretionFallsGlomerular filtration rateInsulinKidneysMedical risk factorsNephrologyOutpatient clinicsProteinsRenal arteriesRenal diseasesRenal failureRetinopathy ePublished: 9 March 2020 Issue Published: July 1, 1992 Copyright & PermissionsCopyright © 1992 by American College of Physicians. All Rights Reserved.Loading ...
No takes yet. Share an insight, caveat, or question.
Jacqueline A. Pugh (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: